ClearPoint Neuro Beheer
Beheer criteriumcontroles 4/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Joe Burnett
Algemeen directeur
US$2.0m
Totale compensatie
Percentage CEO-salaris | 25.9% |
Dienstverband CEO | 7yrs |
Eigendom CEO | 0.9% |
Management gemiddelde ambtstermijn | 3.7yrs |
Gemiddelde ambtstermijn bestuur | 6.1yrs |
Recente managementupdates
Recent updates
Investors Appear Satisfied With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Prospects As Shares Rocket 28%
Sep 14Is ClearPoint Neuro (NASDAQ:CLPT) Weighed On By Its Debt Load?
Aug 16Investors Appear Satisfied With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Prospects As Shares Rocket 26%
Jul 11ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 09ClearPoint Neuro: Macro-Induced Multiple Compression
Apr 25Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?
Apr 19Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report
Mar 15Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?
Jan 04Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Dec 06Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?
Nov 06Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Aug 18ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump
Apr 17Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Jan 03ClearPoint Neuro: Continuous Great Execution
Sep 19ClearPoint Neuro: Picks & Shovels Galore
Aug 19ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Aug 18ClearPoint Neuro: A 'Picks And Shovels' Biotech Company
Jul 25ClearPoint Neuro: Continuous Execution Despite Covid Headwind
May 20Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Apr 25ClearPoint Neuro: A Strong Recovery Play Once COVID Subsides
Mar 18Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$18m |
Mar 31 2024 | n/a | n/a | -US$21m |
Dec 31 2023 | US$2m | US$518k | -US$22m |
Sep 30 2023 | n/a | n/a | -US$22m |
Jun 30 2023 | n/a | n/a | -US$21m |
Mar 31 2023 | n/a | n/a | -US$18m |
Dec 31 2022 | US$2m | US$494k | -US$16m |
Sep 30 2022 | n/a | n/a | -US$16m |
Jun 30 2022 | n/a | n/a | -US$16m |
Mar 31 2022 | n/a | n/a | -US$16m |
Dec 31 2021 | US$1m | US$445k | -US$14m |
Sep 30 2021 | n/a | n/a | -US$12m |
Jun 30 2021 | n/a | n/a | -US$9m |
Mar 31 2021 | n/a | n/a | -US$7m |
Dec 31 2020 | US$784k | US$435k | -US$7m |
Sep 30 2020 | n/a | n/a | -US$7m |
Jun 30 2020 | n/a | n/a | -US$6m |
Mar 31 2020 | n/a | n/a | -US$6m |
Dec 31 2019 | US$864k | US$366k | -US$6m |
Sep 30 2019 | n/a | n/a | -US$5m |
Jun 30 2019 | n/a | n/a | -US$5m |
Mar 31 2019 | n/a | n/a | -US$6m |
Dec 31 2018 | US$515k | US$360k | -US$6m |
Sep 30 2018 | n/a | n/a | -US$7m |
Jun 30 2018 | n/a | n/a | -US$7m |
Mar 31 2018 | n/a | n/a | -US$7m |
Dec 31 2017 | US$930k | US$55k | -US$7m |
Compensatie versus markt: De totale vergoeding ($USD 2.00M ) Joe } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 2.41M ).
Compensatie versus inkomsten: De vergoeding van Joe is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Joe Burnett (47 yo)
7yrs
Tenure
US$1,995,337
Compensatie
Mr. Joseph Michael Burnett, also known as Joe, has been Chief Executive Officer, President and Director of ClearPoint Neuro, Inc. since November 7, 2017. Mr. Burnett has spent his entire career in medical...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
President | 7yrs | US$2.00m | 0.90% $ 3.2m | |
Chief Financial Officer | 3.8yrs | US$930.98k | 0.18% $ 638.0k | |
Chief Business Officer | 1.8yrs | US$838.49k | geen gegevens | |
Chief Operating Officer | 2.1yrs | geen gegevens | 0.13% $ 479.4k | |
General Counsel & Secretary | 3.6yrs | geen gegevens | geen gegevens | |
Vice President of Marketing | 5yrs | geen gegevens | geen gegevens |
3.7yrs
Gemiddelde duur
41.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van CLPT wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
President | 7yrs | US$2.00m | 0.90% $ 3.2m | |
Independent Chairman of the Board | 7.5yrs | US$227.62k | 0.34% $ 1.2m | |
Independent Director | 5.2yrs | US$189.99k | 0.14% $ 484.7k | |
Independent Director | 3.3yrs | US$202.49k | 0.11% $ 386.8k | |
Independent Director | 10.2yrs | US$192.65k | 0.27% $ 955.0k | |
Independent Director | 3yrs | US$182.49k | 0.11% $ 400.8k | |
Independent Director | 10.7yrs | US$194.75k | 0.23% $ 833.0k | |
Director | 4.6yrs | US$174.99k | 0.11% $ 379.3k |
6.1yrs
Gemiddelde duur
64yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van CLPT wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.1 jaar).